GlassScriptPhysician profile
Paul J Rogers
NPI 1669471165
$3,077.85
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $823 · 2021: $1,143 · 2022: $260.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $599.39 | 2019-2022 | |
| Abbott Laboratories | $381.83 | 2019-2022 | |
| Medicure Pharma INC. | $357.95 | 2020 | |
| Amgen INC. | $330.06 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $236.13 | 2019-2022 | |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Medtronic, INC. | $122.61 | 2022 | |
| Sanofi-Aventis U.S. LLC | $96.81 | 2019-2021 | |
| Novo Nordisk INC | $95.10 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.33 | 2019-2021 | |
| Esperion Therapeutics, INC. | $75.57 | 2021 | |
| Boston Scientific Corporation | $72.13 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $69.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.23 | 2019-2021 | |
| Pfizer INC. | $57.30 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $51.24 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $47.28 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $34.71 | 2020-2021 | |
| Lundbeck LLC | $34.53 | 2019-2021 | |
| Medtronic Vascular, INC. | $27.36 | 2019 | |
| Amarin Pharma, INC. | $24.73 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.05 | 2021 | |
| Janssen Scientific Affairs, LLC | $10.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.